CXCR4 and B-cell chronic lymphocytic leukemia: Furthermore, the FoxO1 inhibitor reduces cell-surface CXCR4 and thus potentially impairs CLL cell migration (fold-change, 0.4, P < 0.0001, n = 9; Figure 7H).